Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions

Bone Marrow Transplantation
K van BesienE Kodish

Abstract

Allogeneic stem cell transplantation is increasingly considered as a curative though risky treatment option for adults with sickle cell disease. Little is known about attitudes of adult patients and their health care providers regarding the risks and benefits of transplantation. A survey of 100 patients and their health care providers was undertaken. Assessment of risk was by a reference gamble paradigm. Comparison was made of the characteristics of those accepting substantial risk vs those not accepting risk, as well as assessment of agreement on risks recommended by health care providers and accepted by patients. Sixty-three of 100 patients were willing to accept some short-term risk of mortality in exchange for the certainty of cure. Fifteen patients were willing to accept more than 35% mortality risk. No differences in patient or disease-related variables were identified between those accepting risk and those not accepting risk. There was no agreement between the recommendations of health care providers and the risk accepted by patients. A substantial proportion of adults with sickle cell disease are interested in curative treatment, at the expense of considerable risk. The decision to accept risk is influenced by individua...Continue Reading

References

Nov 7, 1991·The New England Journal of Medicine·E KodishF L Johnson
Jan 1, 1989·Journal of Clinical Epidemiology·D G Froberg, R L Kane
Jun 9, 1994·The New England Journal of Medicine·O S PlattP P Klug
Dec 16, 1995·BMJ : British Medical Journal·A LeeG Serjeant
Aug 8, 1996·The New England Journal of Medicine·O S Platt, E C Guinan
Aug 8, 1996·The New England Journal of Medicine·M C WaltersK M Sullivan
Feb 7, 1998·Artificial Organs·H M Sass
Mar 5, 1998·The New England Journal of Medicine·G J Annas
May 29, 1998·Journal of Medical Ethics·D Prayle, M Brazier
Sep 12, 2000·Bone Marrow Transplantation·K van BesienR Hoffman

❮ Previous
Next ❯

Citations

Dec 20, 2007·Pediatric Hematology and Oncology·Lakshmanan Krishnamurti
Aug 1, 2009·Expert Review of Hematology·Mariane de Montalembert
Jun 15, 2011·Expert Review of Hematology·Ruby Khoury, Miguel R Abboud
Jan 26, 2007·Expert Opinion on Biological Therapy·Lakshmanan Krishnamurti
Oct 27, 2015·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Mark C WaltersEffie Petersdorf
Mar 24, 2010·Pediatric Clinics of North America·Frans J SmiersGuido Lucarelli
Dec 11, 2007·Current Problems in Pediatric and Adolescent Health Care·Lakshmanan KrishnamurtiJakub Tolar
Sep 25, 2004·Pediatric Blood & Cancer·Robert IannoneAllen R Chen
Dec 21, 2011·Pediatric Blood & Cancer·Michael J KellyUNKNOWN Journeys to Recovery Study, HSCT-CHESS™ Study
Jan 10, 2012·British Journal of Haematology·Lori C JordanMichael R DeBaun
Feb 2, 2013·European Journal of Haematology·Susanne Matthes-MartinMilen Minkov
Jan 14, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Naynesh KamaniJeffrey P Kahn
Jan 31, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Suparno Chakrabarti, David Bareford
Jun 5, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Michael RothRosanna Ricafort
Jan 18, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Jakub TolarMark C Walters
Aug 22, 2003·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Robert IannoneMark C Walters
Mar 15, 2015·Current Opinion in Hematology·Mark C Walters
Jun 4, 2016·British Journal of Haematology·Staci D ArnoldLakshmanan Krishnamurti
Mar 19, 2014·Journal of Pediatric Hematology/oncology·Bethany MiklesNancy S Green
May 12, 2017·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Ryan M AntielLamia P Barakat
Oct 2, 2013·Therapeutic Advances in Hematology·Shalini Shenoy
Feb 23, 2019·Journal of Pediatric Hematology/oncology·Alicia M StallingsConnie M Piccone
Nov 26, 2002·Hematology·Mark C WaltersElliott Vichinsky
Nov 13, 2019·British Journal of Haematology·Alicia M StallingsConnie M Piccone
Oct 5, 2019·Journal of Clinical Medicine·Santosh L Saraf, Damiano Rondelli
May 26, 2018·Pediatric Blood & Cancer·Monica L Hulbert, Shalini Shenoy
Jul 26, 2017·Stem Cells International·Arcangelo LisoEmanuela Turillazzi
Jul 5, 2019·Nature Medicine·Amanda MacPherson, Jonathan Kimmelman
Oct 10, 2020·Pediatric Blood & Cancer·Cynthia B SinhaLakshmanan Krishnamurti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.